Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Orphazyme A/S (ORPHA.CO)

Copenhagen - Copenhagen Real Time Price. Currency in DKK
Add to watchlist
26.38-0.38 (-1.42%)
At close: 4:59PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close26.76
Open26.90
Bid26.08 x 0
Ask26.40 x 0
Day's Range25.74 - 26.90
52 Week Range22.02 - 109.10
Volume191,400
Avg. Volume209,829
Market Cap922.039M
Beta (5Y Monthly)0.70
PE Ratio (TTM)N/A
EPS (TTM)-25.55
Earnings DateAug 31, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est155.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ORPHA.CO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Benzinga

      50 Biggest Movers From Yesterday

      Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target. Waitr Holdings Inc (NASDAQ: WTRH) gained 58.5% to close at $1.27 after Morgan Stanley reported a 10.3% passive stake in the company. Sono-Tek Corporation (NASDAQ: SOTK) jumped 44.2% to close at $6.49. Sono-Tek reported second-quarter FY22 net sales growth of 17% year-on-year to $4.07 million. Sono

    • GlobeNewswire

      Modified long-term share-based incentive program for 2021

      Orphazyme A/SCompany announcement No. 23/2021Company Registration No. 32266355 Copenhagen, Denmark, October 7, 2021 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US)), a late-stage biopharmaceutical company, has today introduced a modified long-term incentive program for 2021 (the “LTIP”) with the view to retaining members of the Executive Management and other employees of the Group, while also creating an incentive for a positive share price development and corporate performance for the benefit of the

    • Benzinga

      The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

      Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (NASDAQ: AVDL) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Cytokinetics, Incorporated (NASDAQ: CYTK) Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) Legend Biotech Corporation (NASDAQ: LEGN) Merck & Co, Inc. (NYSE: MRK) Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) Legend Biot

    Advertisement
    Advertisement